Abstract

Pokeweed mitogen (PWM) and ricin are both lectins derived from plant seeds. They are glycoproteins and share the ability to agglutinate a variety of animal cells particularly erythrocytes. Preliminary to development of a system to screen for the effect of environmental mutagens on the frequency of lectin resistant mutants we studied the effect of these 2 lectins on protein synthesis in long-term lymphoid lines. Ricin, a highly toxic compound is a known inhibitor of protein synthesis in other cell systems. PWM has primarily been evaluated for its mitogenic effect. Four lymphoid lines were studied: 8866 and GM1531 which are B cell lines, and CCRC/CEM and MOLT 4 which are considered to be T cell lines. Ricin (50 ug/ml) completely inhibited protein synthesis by 2 hours in all 4 lines as measured by the uptake of 3H leucine. PWM appeared more specific and at a concentration of 500 ug/ml inhibited protein synthesis only in the B lines (8866 and GM1531). This effect was maximal at 5 hours. To investigate the reason for the differential effect of PWM on T & B cells, 125I labeled PWM was incubated with 8866 and MOLT 4 to see if an increased binding to B cells could be demonstrated. A significantly greater number of counts bound to 8866 compared to MOLT 4. As lectins bind to cell surface carbohydrates, the possibility that this may represent a difference in the composition or arrangement of the surface glycoproteins is being investigated.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.